LAB MEMBERS (Click on name for publications)
|
THOMAS CONRADS
Co-Director, Clinical Proteomics Facility B.S. Biochemistry/Biophysics (Washington State University) Ph.D. Biochemistry (Ohio State University) Thomas P. Conrads is an associate professor of pharmacology, biomedical informatics and medicine at the University of Pittsburgh School of Medicine and co-directs the Clinical Proteomics Facility in the University of Pittsburgh Cancer Institute. He obtained his Ph.D. at the Ohio State University in biochemistry and received postdoctoral training at Pacific Northwest National Laboratory. His research program is focused on developing new technologies in chemistry and biology toward characterization of proteomic and metabolomic changes associated with clinically relevant questions in cancer biology. The goal of these efforts is toward enhanced cancer patient management through improved early detection, patient stratification, and monitoring for therapeutic efficacy, outcome and recurrence. [email protected] |
 |
NICHOLAS W. BATEMAN Graduate Student BSc. Biological Sciences (SUNY at Buffalo) Ph.D. Pharmacology (Anticipated) [email protected] |
 |
MELANIE S. FLINT Research Instructor BSc. Biology (Univ. of Portsmouth, England) MSc. Applied Toxicology (Univ. of Portsmouth and Glaxo Welcome, London, England) Ph.D. Biochemical Toxicology (Imperial College, London, England) I am currently a research instructor with a special interest in hormonal influences on cell cycle regulation, targeted molecular therapies, drug metabolism, drug resistance and cancer. My primary research project involves the direct interplay between stress hormones (cortisol, NE, and E), cancer and chemotherapy. This is accomplished through a mechanistic study of administration of stress hormones to cancerous cells, and observing these effects both in vitro and in rodent models. My goal is to identify predictive characteristics for molecular response, elucidating the mechanism of action of hormones in cancerous cells, and characterizing the genomic/proteomic profiles encoding cell cycle regulation. [email protected] |
|
BRIAN HOOD
|
 |
JENNIFER SUTTON Visiting Scientist BRIMS Center, Thermo Fisher Scientific Ph.D. Chemistry (University of Virginia) BS. Chemistry (West Virginia University) Research focus is on developing new technologies that bridge the fields of chemical-biology and clinical medicine with the objective of applying these developments for the characterization of proteomic changes associated with cancer pathophysiology, ascribing to the philosophy that the most significant biomedical problems require creative multidisciplinary approaches for their solution. As a visiting industrial scientist I hope to bring new technologies and opportunities to the university in exploring and developing workflows for cancer biomarker investigation. [email protected] [email protected] |
 |
NICOLAS A. STEWART Research Instructor Ph.D. Chemistry (Univ. of Ottawa) Small molecule and drug/metabolite assays by MS. [email protected] |
ALUMNI |
|
 |
SUSAN ABBATIELLO
Post-Doctoral Associate BA. Chemistry (College of the Holy Cross) Ph.D. Analytical Chemistry (Univ. of Florida) [email protected] |
